CDSCO panel rejects Glenmark proposal for use of Nitric Oxide Nasal Spray for prevention of COVID 19
Advertisement
Citing lack of strong evidence on the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected the drug major Glenmark's proposal for the additional indication of Nitric Oxide Nasal Spray.
This came after the drug major Glenmark presented their proposal before the committee regarding the use of Nitric Oxide Nasal Spray for prevention of COVID-19 infection
For more details, check out the full story on the link below:
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.